AGTR1 and pulmonary arterial hypertension: Although this was largely consistent with previous studies demonstrating no significant hemodynamic benefit of AT1R antagonism in MCT PAH (4), it suggested that the previously described beneficial effects of AT1R antagonism in PAH were not directly mediated through an improvement in RV hemodynamics.